ArticleNanomaterials (Basel, Switzerland)2020
Failure Analysis of Ultra High-Performance Fiber-Reinforced Concrete Structures Enhanced with Nanomaterials by Using a Diffuse Cohesive Interface Approach.
Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- From Pre-Swelling to Performance Enhancement: Mechanisms and Effects of an Instant Ultra High-Performance Bituminous Material Modifier.Materials (Basel, Switzerland) · 2026Article
- Novel Calculation Method for the Shear Capacity of a UHPC Beam with and without Web Reinforcement.Materials (Basel, Switzerland) · 2023Article
- Theoretical and Experimental Investigation on the Flexural Behaviour of Prestressed NC-UHPC Composite Beams.Materials (Basel, Switzerland) · 2023Article
- Nano-Silica-Modified Concrete: A Bibliographic Analysis and Comprehensive Review of Material Properties.Nanomaterials (Basel, Switzerland) · 2022Review
- Effects of Low Temperatures on Flexural Strength of Macro-Synthetic Fiber Reinforced Concrete: Experimental and Numerical Investigation.Materials (Basel, Switzerland) · 2022Article
- Multiscale Innovative Materials and Structures (MIMS).Nanomaterials (Basel, Switzerland) · 2021Article
- Shear Strength of Hybrid Fibre-Reinforced Ternary Blend Geopolymer Concrete Beams under Flexure.Materials (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Recent progresses in nanotechnology have clearly shown that the incorporation of nanomaterials within concrete elements leads to a sensible increase in strength and toughness, especially if used in combination with randomly distributed short fiber reinforcements, as for ultra high-performance fiber-reinforced concrete (UHPFRC). Current damage models often are not able to accurately predict the development of diffuse micro/macro-crack patterns which are typical for such concrete structures. In this work, a diffuse cohesive interface approach is proposed to predict the structural response of UHPFRC structures enhanced with embedded nanomaterials. According to this approach, all the internal mesh boundaries are regarded as potential crack segments, modeled as cohesive interfaces equipped with a mixed-mode traction-separation law suitably calibrated to account for the toughening effect of nano-reinforcements. The proposed fracture model has been firstly validated by comparing the failure simulation results of UHPFRC specimens containing different fractions of graphite nanoplatelets with the available experimental data. Subsequently, such a model, combined with an embedded truss model to simulate the concrete/steel rebars interaction, has been used for predicting the load-carrying capacity of steel bar-reinforced UHPFRC elements enhanced with nanoplatelets. The numerical outcomes have shown the reliability of the proposed model, also highlighting the role of the nano-reinforcement in the crack width control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.